DK516585D0 - Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkoer - Google Patents

Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkoer

Info

Publication number
DK516585D0
DK516585D0 DK516585A DK516585A DK516585D0 DK 516585 D0 DK516585 D0 DK 516585D0 DK 516585 A DK516585 A DK 516585A DK 516585 A DK516585 A DK 516585A DK 516585 D0 DK516585 D0 DK 516585D0
Authority
DK
Denmark
Prior art keywords
expression
hbxag
markets
vector containing
expression vector
Prior art date
Application number
DK516585A
Other languages
English (en)
Other versions
DK175364B1 (da
DK516585A (da
Inventor
Ann M Moriarty
Hannah Alexander
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK516585A publication Critical patent/DK516585A/da
Publication of DK516585D0 publication Critical patent/DK516585D0/da
Application granted granted Critical
Publication of DK175364B1 publication Critical patent/DK175364B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Image Generation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Editing Of Facsimile Originals (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK198505165A 1984-03-08 1985-11-08 Antigent syntetisk peptid, antigen polymer samt receptormolekyle DK175364B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US58757084A 1984-03-08 1984-03-08
US58757084 1984-03-08
US64814284 1984-09-07
US06/648,142 US4777240A (en) 1984-03-08 1984-09-07 SV40 expression vector containing HBxAg as an expression marker
US8500359 1985-03-06
PCT/US1985/000359 WO1985003950A1 (en) 1984-03-08 1985-03-06 A sv40 expression vector containing hbxag as an expression marker

Publications (3)

Publication Number Publication Date
DK516585A DK516585A (da) 1985-11-08
DK516585D0 true DK516585D0 (da) 1985-11-08
DK175364B1 DK175364B1 (da) 2004-09-13

Family

ID=27080076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198505165A DK175364B1 (da) 1984-03-08 1985-11-08 Antigent syntetisk peptid, antigen polymer samt receptormolekyle

Country Status (13)

Country Link
US (3) US4777240A (da)
EP (1) EP0155147B1 (da)
JP (1) JPH0832721B2 (da)
AT (1) ATE59185T1 (da)
AU (1) AU594642B2 (da)
CA (1) CA1340732C (da)
DE (1) DE3580927D1 (da)
DK (1) DK175364B1 (da)
FI (1) FI86585C (da)
IL (1) IL74544A (da)
NO (1) NO172394C (da)
NZ (1) NZ211357A (da)
WO (1) WO1985003950A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
EP0228036A3 (en) * 1985-12-18 1988-09-07 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
EP0300213A1 (en) * 1987-06-22 1989-01-25 Hexal-Pharma Gentechnik GmbH & Co. KG Hepatitis a viral peptide particle immunogens
WO1989004964A1 (en) * 1987-11-16 1989-06-01 Fox Chase Cancer Center Determination of anti-pol as an early marker or viral hepatitis infection
JPH0260589A (ja) * 1988-08-26 1990-03-01 Natl Sci Council バクテリオファージｍ１３の遺伝子□ｄ２プロモーターを使用した大腸菌中での外来タンパクの高レベル産生
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome
US5872206A (en) * 1994-10-06 1999-02-16 The General Hospital Corporation Compositions and methods for interfering wtih hepatitis B virus infection
DE69820486D1 (de) * 1998-01-19 2004-01-22 Mogam Biotechnology Res Inst Y Liposomen, enthaltend peptidantigene, welche vom x-protein aus hepatitis b virus abstammen
WO1999039200A1 (en) * 1998-01-29 1999-08-05 Thomas Jefferson University Molecular markers for diagnosing hepatocellular carcinoma
US6638903B2 (en) 2002-01-15 2003-10-28 Milliken & Company Non-staining red colorants and liquid fabric softener formulations comprising such non-staining colorants
US6593289B1 (en) 2002-01-15 2003-07-15 Milliken & Co. Liquid fabric softener formulations comprising hemicyanine red colorants
US7281957B2 (en) 2004-07-13 2007-10-16 Panduit Corp. Communications connector with flexible printed circuit board
US7357683B2 (en) 2005-07-15 2008-04-15 Panduit Corp. Communications connector with crimped contacts
WO2007110098A1 (en) * 2006-03-29 2007-10-04 Institut National De La Sante Et De La Recherche Medicale HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV
NZ586074A (en) * 2010-06-10 2013-07-26 Auckland Uniservices Ltd LCLRP peptides, constructs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
DE3580927D1 (de) 1991-01-31
NO172394B (no) 1993-04-05
AU4067285A (en) 1985-09-24
US5183734A (en) 1993-02-02
DK175364B1 (da) 2004-09-13
FI854395L (fi) 1985-11-07
DK516585A (da) 1985-11-08
NO854448L (no) 1986-01-06
US5534405A (en) 1996-07-09
NO172394C (no) 1993-07-14
EP0155147A2 (en) 1985-09-18
FI86585B (fi) 1992-05-29
AU594642B2 (en) 1990-03-15
ATE59185T1 (de) 1991-01-15
JPS61502094A (ja) 1986-09-25
EP0155147A3 (en) 1985-11-06
FI86585C (fi) 1992-09-10
FI854395A0 (fi) 1985-11-07
IL74544A (en) 1994-11-11
WO1985003950A1 (en) 1985-09-12
NZ211357A (en) 1988-08-30
CA1340732C (en) 1999-09-14
EP0155147B1 (en) 1990-12-19
JPH0832721B2 (ja) 1996-03-29
US4777240A (en) 1988-10-11
IL74544A0 (en) 1985-06-30

Similar Documents

Publication Publication Date Title
DK516585A (da) Sv40-ekspressionsvektor indeholdende hbxag-som ekspressionsmarkaer
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
ATE91714T1 (de) Transformation von trichoderma.
DE68915070D1 (de) Zellkultur-Reaktor.
ES2038148T3 (es) Preparaciones cosmeticas.
GR3026114T3 (en) Methods for culturing HCV in B- or T-lymphocyte cell lines
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
ES2043607T3 (es) Agentes fibrinoliticos modificados.
EP0161770A3 (en) Lysing agent for analysis of peripheral blood cells
AU583101B2 (en) Boronic acid adducts of technetium-99m doxime complexes
DE3477845D1 (en) Lewis blood group phenotype assay
ES2086383T3 (es) Deteccion de cepas fungicas mutantes.
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
EP0160486A3 (en) Monoclonal antibodies
EP0139076A3 (en) Human-parathyroid hormone (human-pth) producing hybrid vectors, human-parathyroid hormone gene, eucaryotic cells containing the hybrid vector and their use
IL86058A0 (en) Production of proteins
AU527196B2 (en) Enzymatic method for detecting cancer in mammalian tissue
DE59010897D1 (de) Expressionsvektoren zur Synthese von Proteinen in der Spalthefe Schizosaccharomyces pombe
AU553409B2 (en) Hybrid vectors and process for improving the amplification and expression of hybrid vectors by use of mitochondrial dna
IL83435A (en) Dna construct for expression of genes in yeast, an expression vector containing it and yeast transformed with said expression vector
DK302785A (da) Monoklonale antistoffer overfor humant interferon-gamma, hybridcellelinier, der frembringer disse antistoffer, antistoffernes anvendelse og fremgangsmaader til fremstilling deraf
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
DE69314633D1 (de) Methoden und Zusammensetzungen um die Sensitivität eine Zellegegen DNA-Zerstörende Agentien zu erhöhen
IT8420870A0 (it) Procedimento e impianto di concentrazione di idrogeno.

Legal Events

Date Code Title Description
PUP Patent expired